866-997-4948(US-Canada Toll Free)

Idiopathic pulmonary fibrosis (IPF)- Epidemiology Forecast To 2023

Published By :

DelveInsight

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 60 Pages

DelveInsight Idiopathic pulmonary fibrosis (IPF) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Idiopathic pulmonary fibrosis (IPF) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Idiopathic pulmonary fibrosis (IPF) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Idiopathic pulmonary fibrosis (IPF). The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope of the Report
The Report includes the prevalent population and how will it change over the next eight years.
Prevalent or incident cases segmented by age and sex.
Coverage of key Idiopathic pulmonary fibrosis (IPF) subpopulations and its prevalent or incident cases
The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits
The report will help in developing business strategies by understanding the trends shaping and driving the global Idiopathic pulmonary fibrosis (IPF) market.
Identifying prevalent patient populations as well as risk factors in the global Idiopathic pulmonary fibrosis (IPF) market will help to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Idiopathic pulmonary fibrosis (IPF) therapeutics in each of the markets covered.

1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
Key Findings
4. Idiopathic pulmonary fibrosis (IPF)Overview
Idiopathic pulmonary fibrosis (IPF) Definition
Pathophysiology
Symptoms
Etiology
5. Risk Factors Associated with Idiopathic pulmonary fibrosis (IPF)
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2013-2023
Prevalent & Incident Cases by Category-2013-2023
o Age-Specific Prevalent/ Incident Cases of Idiopathic pulmonary fibrosis (IPF)
o Sex-Specific Prevalent/Incident Cases of Idiopathic pulmonary fibrosis (IPF)
o Disease Type Specific Prevalent/Incident Cases of Idiopathic pulmonary fibrosis (IPF)
Prevalent & Incident Cases by 7 MM-2013-2023
o Idiopathic pulmonary fibrosis (IPF) Epidemiology of United States-2023
o Idiopathic pulmonary fibrosis (IPF) Epidemiology of United Kingdom-2023
o Idiopathic pulmonary fibrosis (IPF) Epidemiology of Germany-2023
o Idiopathic pulmonary fibrosis (IPF) Epidemiology of France-2023
o Idiopathic pulmonary fibrosis (IPF) Epidemiology of Spain-2023
o Idiopathic pulmonary fibrosis (IPF) Epidemiology of Italy-2023
o Idiopathic pulmonary fibrosis (IPF) Epidemiology of Japan-2023
8. Key Takeaways
9. Appendix
10. Report Methodology
11. Consulting Services
12. Disclaimer
13. About Us

List of Table

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Idiopathic pulmonary fibrosis (IPF) Global Epidemiology, (2013-2023)
Table 6: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), US (2013-2023)
Table 7: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), US (2013-2023)
Table 8: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population, US (2013-2023)
Table 9: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), United Kingdom (2013-2023)
Table 10: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), United Kingdom (2013-2023)
Table 11: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population, United Kingdom (2013-2023)
Table 12: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), Germany (2013-2023)
Table 13: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), Germany (2013-2023)
Table 14: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population, Germany (2013-2023)
Table 15: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), France (2013-2023)
Table 16: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), France (2013-2023)
Table 17: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population, France (2013-2023)
Table 18: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), Italy (2013-2023)
Table 19: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), Italy (2013-2023)
Table 20: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population, Italy (2013-2023)
Table 21: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), Spain (2013-2023)
Table 22: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), Spain (2013-2023)
Table 23: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population, Spain (2013-2023)
Table 24: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), Japan (2013-2023)
Table 25: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), Japan (2013-2023)
Table 26: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population, Japan (2013-2023)

List of Chart

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Idiopathic pulmonary fibrosis (IPF) Global Epidemiology, (2013-2023)
Figure 4: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), US (2013-2023)
Figure 5: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), US (2013-2023)
Figure 6: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population,US (2013-2023)
Figure 7: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), United Kingdom (2013-2023)
Figure 8: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), United Kingdom (2013-2023)
Figure 9: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population,United Kingdom (2013-2023)
Figure 10: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), Germany (2013-2023)
Figure 11: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), Germany (2013-2023)
Figure 12: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population,Germany (2013-2023)
Figure 13: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), France (2013-2023)
Figure 14: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), France (2013-2023)
Figure 15: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population,France (2013-2023)
Figure 16: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), Italy (2013-2023)
Figure 17: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), Italy (2013-2023)
Figure 18: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population,Italy (2013-2023)
Figure 19: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), Spain (2013-2023)
Figure 20: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), Spain (2013-2023)
Figure 21: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population,Spain (2013-2023)
Figure 22: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) (Ages =XX Years), Japan (2013-2023)
Figure 23: Prevalent Cases of Idiopathic pulmonary fibrosis (IPF) By Sex (Males & Females), Japan (2013-2023)
Figure 24: Prevalent Cases By Idiopathic pulmonary fibrosis (IPF) Sub-population,Japan (2013-2023)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *